2023
Support of Patient Organisations & Grants and Donations
| Recipient | Activity Supported | Type | Value (£) |
| Arthritis and Musculoskeletal Alliance |
ARMA Associate Membership |
P.O | £5,825.00 |
| Arthritis and Musculoskeletal Alliance | Patient voice panel participation | P.O | £240.00 |
| Arthritis and Musculoskeletal Alliance | Global Commercial Summit participation | P.O | £180.00 |
| Arthritis and Musculoskeletal Alliance | Patient voice panel participation |
P.O | £240.00 |
| MacMillan Cancer Support | Speaker at Change Pain event | P.O | £333.00 |
2022
Support of Patient Organisations & Grants and Donations
| Recipient | Activity Supported | Type | Value (£) |
| ARMA (Arthritis & Musculoskeletal Alliance) | ARMA Associate membership | P.O | £5,000 |
| ARMA (Arthritis & Musculoskeletal Alliance) | ARMA MSK Health Inequalities | P.O | £10,000 |
| MacMillan Cancer Support | Speaker @ Change Pain | GAD | £2427,7 |
Grünenthal have also provided a service evaluation tool to support the local evaluation of the effectiveness of analgesics already used in routine clinical practice. This service is provided to support and inform local decision-making, and has been utilised by the following HCOs:
- Aintree Hospital, Liverpool
- Calderdale Royal Hospital
- Doncaster Royal Infirmary
- Glangwili Hospital
- James Cook Hospital
- NHS Highland Chronic Pain Service
- Queen Elizabeth Hospital, London
- St. Woolos Hospital, Newport
- Ulster Hospital
- Whiston Hospital
- Whitegate Drive Health Centre, Blackpool
M-N/A-UK-05-25-0004 June 2025